Fennec Pharma-Adherex Technologies Inc. (FENC) Reports Q2 Loss, Lags Revenue Estimates

Adherex Technologies Inc. (FENC) came out with a quarterly loss of $0.20 per share versus the Zacks Consensus Estimate of$ 0.06. This compares to loss of $0.21 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -433.33%. A quarter ago, it was expected that this company would post earnings of$ 0.49 per share when it actually produced earnings of $0.41, delivering a surprise of -16.33%. Over the last four quarters, the company has ...